Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 99 | ECE2024 | Next issue

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Symposia

Osteoporosis Conundrums

Previous section
Neural pathways controlling feeding behaviour: impact of circulating hormones
Table of contents
Next section
Emerging aspects of menopause

ea0099s4.1 | Osteoporosis Conundrums | ECE2024

Abstract unavailable...
0 shares

ea0099s4.2 | Osteoporosis Conundrums | ECE2024

Abstract unavailable...
0 shares

ea0099s4.3 | Osteoporosis Conundrums | ECE2024

Symposium: ‘Does sclerostin inhibition increase cardiovascular risk?’

Tsourdi Elena

In the ARCH study1, romosozumab was compared with an active comparator, alendronate. Unexpectedly, an imbalance in adjudicated serious cardiovascular AEs was observed during the first year of the study, triggering numerous discussions among experts and giving rise to hypotheses regarding the mechanism leading to such a difference. However, it should be noted that an even lower cardiovascular risk in high-dose romosozumab treatment as compared to placebo was reported...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more